Robert F. Apple, President & CEO at ANTARES PHARMA, INC. (ATRS), bought 60,000 shares at $0.72 ($43K) on 2016-03-18, disclosed to the SEC on 2016-03-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ATRS | SELL | 2019-12-11 | $2.0M | — | Filing → |
| ATRS | SELL | 2018-08-23 | $161K | — | Filing → |
| ATRS | SELL | 2017-04-05 | $120K | — | Filing → |